{"paper_id":"d73d354f-3eaf-4142-a7c8-e0bff8894c3d","body_text":"Abstract\nUterine leiomyomas are the most common benign tumors of the female genital tract. Fibroids are associated with a variety of clinical problems, including bleeding disorders, bulk-related symptoms, and infertility. For women who wish to preserve their uterus, fibroids can be surgically removed by hysteroscopy, laparoscopy, or laparotomy. The only definitive solution, however, is hysterectomy. The choice of treatment must be made after carefully weighing alternative treatment methods, such as expectant management, medical treatment, and interventional radiology, and obtaining informed consent. The optimal treatment decision takes into account the interests and wishes of the patient as well as the practical feasibility in the clinical setup. Surgical skills and experience are an important factor, as surgical procedures on the uterus are not without risk, and can lead to severe complications. The decision to operate anticipates an improvement of the initial situation, and the appropriate surgical approach is of the utmost importance.\nSimilar content being viewed by others\nReferences\nButtram Jr VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36(4):433–45.\nLefebvre G, Vilos G, Allaire C, Jeffrey J, Arneja J, Birch C, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2003;25(5):396–418. quiz 9–22.\nAlkatout I, Mundhenke C, Maass N, Schem C. Die Rolle der Angiogenese und seiner Inhibitoren in der Gynäkologie. Der Gynäkologe. 2012. (in press).\nPeddada SD, Laughlin SK, Miner K, Guyon JP, Haneke K, Vahdat HL, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A. 2008;105(50):19887–92. doi:10.1073/pnas.0808188105.\nLaughlin SK, Hartmann KE, Baird DD. Postpartum factors and natural fibroid regression. Am J Obstet Gynecol. 2011;204(6):496 e1–6. doi:10.1016/j.ajog.2011.02.018.\nZaima A, Ash A. Fibroid in pregnancy: characteristics, complications, and management. Postgrad Med J. 2011;87(1034):819–28. doi:10.1136/postgradmedj-2011-130319.\nMarjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2006;2, CD003855. doi:10.1002/14651858.CD003855.pub2.\nAl-Hendy A, Lee EJ, Wang HQ, Copland JA. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. Am J Obstet Gynecol. 2004;191(5):1621–31. doi:10.1016/j.ajog.2004.04.022.\nEdwards RD, Moss JG, Lumsden MA, Wu O, Murray LS, Twaddle S, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med. 2007;356(4):360–70. doi:10.1056/NEJMoa062003.\nvan der Kooij SM, Bipat S, Hehenkamp WJ, Ankum WM, Reekers JA. Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;205(4):17 e1–18. doi:10.1016/j.ajog.2011.03.016.\nKim HS, Baik JH, Pham LD, Jacobs MA. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol. 2011;18(8):970–6. doi:10.1016/j.acra.2011.03.008.\nFunaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 2009;34(5):584–9. doi:10.1002/uog.7455.\nGynaecologists RCoOa. Preventing entry-related gynaecological laparoscopic injuries. RCOG Green-top Guideline. 2008;No.49:1–10.\nWallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104(2):393–406. doi:10.1097/01.aog.0000136079.62513.39.\nKim MS, Uhm YK, Kim JY, Jee BC, Kim YB. Obstetric outcomes after uterine myomectomy: laparoscopic versus laparotomic approach. Obstet Gynecol Sci. 2013;56(6):375–81. doi:10.5468/ogs.2013.56.6.375.\nLonnerfors C, Persson J. Pregnancy following robot-assisted laparoscopic myomectomy in women with deep intramural myomas. Acta Obstet Gynecol Scand. 2011;90(9):972–7. doi:10.1111/j.1600-0412.2011.01207.x.\nMettler L, Schollmeyer T, Tinelli A, Malvasi A, Alkatout I. Complications of uterine fibroids and their management, surgical management of fibroids, laparoscopy and hysteroscopy versus hysterectomy, haemorrhage, adhesions, and complications. Obstet Gynecol Int. 2012;2012:791248. doi:10.1155/2012/791248.\nDi Spiezio Sardo A, Mazzon I, Bramante S, Bettocchi S, Bifulco G, Guida M, et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update. 2008;14(2):101–19. doi:10.1093/humupd/dmm041.\nEmanuel MH, Hart A, Wamsteker K, Lammes F. An analysis of fluid loss during transcervical resection of submucous myomas. Fertil Steril. 1997;68(5):881–6.\nWamsteker K, Emanuel MH, de Kruif JH. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension. Obstet Gynecol. 1993;82(5):736–40.\nHart R, Molnar BG, Magos A. Long term follow up of hysteroscopic myomectomy assessed by survival analysis. Br J Obstet Gynaecol. 1999;106(7):700–5.\nMettler L, Sammur W, Alkatout I, Schollmeyer T. Imaging in gynecologic surgery. Womens Health (Lond Engl). 2011;7(2):239–48. doi:10.2217/whe.11.6. quiz 49–50.\nVarma R, Soneja H, Clark TJ, Gupta JK. Hysteroscopic myomectomy for menorrhagia using Versascope bipolar system: efficacy and prognostic factors at a minimum of one year follow up. Eur J Obstet Gynecol Reprod Biol. 2009;142(2):154–9. doi:10.1016/j.ejogrb.2008.10.006.\nLoffer FD, Bradley LD, Brill AI, Brooks PG, Cooper JM. Hysteroscopic fluid monitoring guidelines. J Am Assoc Gynecol Laparosc. 2000;7(3):438.\nJansen FW, Vredevoogd CB, van Ulzen K, Hermans J, Trimbos JB, Trimbos-Kemper TC. Complications of hysteroscopy: a prospective, multicenter study. Obstet Gynecol. 2000;96(2):266–70.\nPropst AM, Liberman RF, Harlow BL, Ginsburg ES. Complications of hysteroscopic surgery: predicting patients at risk. Obstet Gynecol. 2000;96(4):517–20.\nParker WH, Rodi IA. Patient selection for laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 1994;2(1):23–6.\nAlkatout I, Bojahr B, Dittmann L, Warneke V, Mettler L, Jonat W, et al. Precarious preoperative diagnostics and hints for the laparoscopic excision of uterine adenomatoid tumors: two exemplary cases and literature review. Fertil Steril. 2010;95(3):1119 e5–8. doi:10.1016/j.fertnstert.2010.10.017.\nDueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002;186(3):409–15.\nAlkatout I, Honemeyer U, Strauss A, Tinelli A, Malvasi A, Jonat W, et al. Clinical diagnosis and treatment of ectopic pregnancy. Obstet Gynecol Surv. 2013;68(8):571–81. doi:10.1097/OGX.0b013e31829cdbeb.\nAlkatout I, Schollmeyer T, Hawaldar NA, Sharma N, Mettler L. Principles and safety measures of electrosurgery in laparoscopy. JSLS. 2012;16(1):130–9. doi:10.4293/108680812X13291597716348.\nAlkatout I, Stuhlmann-Laeisz C, Mettler L, Jonat W, Schollmeyer T. Organ-preserving management of ovarian pregnancies by laparoscopic approach. Fertil Steril. 2011;95(8):2467–70 e1-2. doi:10.1016/j.fertnstert.2010.12.060.\nKongnyuy EJ, Wiysonge CS. Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev. 2011;11, CD005355. doi:10.1002/14651858.CD005355.pub4.\nZhao F, Jiao Y, Guo Z, Hou R, Wang M. Evaluation of loop ligation of larger myoma pseudocapsule combined with vasopressin on laparoscopic myomectomy. Fertil Steril. 2010;95(2):762–6. doi:10.1016/j.fertnstert.2010.08.059.\nTinelli A, Mettler L, Malvasi A, Hurst B, Catherino W, Mynbaev OA, et al. Impact of surgical approach on blood loss during intracapsular myomectomy. Minim Invasive Ther Allied Technol. 2013. doi:10.3109/13645706.2013.839951.\nCelik H, Sapmaz E. Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. Fertil Steril. 2003;79(5):1207–10.\nMettler L, Sammur W, Schollmeyer T, Alkatout I. Cross-linked sodium hyaluronate, an anti-adhesion barrier gel in gynaecological endoscopic surgery. Minim Invasive Ther Allied Technol. 2013;22(5):260–5. doi:10.3109/13645706.2012.751034.\nMettler L, Schollmeyer T, Alkatout I. Adhesions during and after surgical procedures, their prevention and impact on women's health. Womens Health (Lond Engl). 2012;8(5):495–8. doi:10.2217/whe.12.34.\nTulandi T, Murray C, Guralnick M. Adhesion formation and reproductive outcome after myomectomy and second-look laparoscopy. Obstet Gynecol. 1993;82(2):213–5.\nTsuji S, Takahashi K, Imaoka I, Sugimura K, Miyazaki K, Noda Y. MRI evaluation of the uterine structure after myomectomy. Gynecol Obstet Invest. 2006;61(2):106–10. doi:10.1159/000089144.\nD'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2009;116(1):131–9. doi:10.1016/j.ygyno.2009.09.023.\nMukhopadhaya N, De Silva C, Manyonda IT. Conventional myomectomy. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):677–705. doi:10.1016/j.bpobgyn.2008.01.012.\nDiscepola F, Valenti DA, Reinhold C, Tulandi T. Analysis of arterial blood vessels surrounding the myoma: relevance to myomectomy. Obstet Gynecol. 2007;110(6):1301–3. doi:10.1097/01.AOG.0000290331.95709.26.\nPundir J, Pundir V, Walavalkar R, Omanwa K, Lancaster G, Kayani S. Robotic-assisted laparoscopic vs abdominal and laparoscopic myomectomy: systematic review and meta-analysis. J Minim Invasive Gynecol. 2013;20(3):335–45. doi:10.1016/j.jmig.2012.12.010.\nBarakat EE, Bedaiwy MA, Zimberg S, Nutter B, Nosseir M, Falcone T. Robotic-assisted, laparoscopic, and abdominal myomectomy: a comparison of surgical outcomes. Obstet Gynecol. 2011;117(2 Pt 1):256–65. doi:10.1097/AOG.0b013e318207854f.\nMettler L, Clevin L, Ternamian A, Puntambekar S, Schollmeyer T, Alkatout I. The past, present and future of minimally invasive endoscopy in gynecology: a review and speculative outlook. Minim Invasive Ther Allied Technol. 2013;22(4):210–26. doi:10.3109/13645706.2013.823451.\nSchollmeyer T, Mettler L, Jonat W, Alkatout I. Roboterchirurgie in der Gynäkologie. Der Gynäkologe. 2011;44(3):196–201. doi:10.1007/s00129-010-2709-z.\nGeorge A, Eisenstein D, Wegienka G. Analysis of the impact of body mass index on the surgical outcomes after robot-assisted laparoscopic myomectomy. J Minim Invasive Gynecol. 2009;16(6):730–3. doi:10.1016/j.jmig.2009.07.014.\nFalcone T, Parker WH. Surgical management of leiomyomas for fertility or uterine preservation. Obstet Gynecol. 2013;121(4):856–68. doi:10.1097/AOG.0b013e3182888478.\nGarry R, Fountain J, Brown J, Manca A, Mason S, Sculpher M, et al. EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. Health Technol Assess. 2004;8(26):1–154.\nDietl J, Wischhusen J, Hausler SF. The post-reproductive Fallopian tube: better removed? Hum Reprod. 2011;26(11):2918–24. doi:10.1093/humrep/der274.\nWorldwide AAMIG. AAGL position statement: robotic-assisted laparoscopic surgery in benign gynecology. J Minim Invasive Gynecol. 2013;20(1):2–9. doi:10.1016/j.jmig.2012.12.007.\nMeeks GR, Harris RL. Surgical approach to hysterectomy: abdominal, laparoscopy-assisted, or vaginal. Clin Obstet Gynecol. 1997;40(4):886–94.\nMazdisnian F, Kurzel RB, Coe S, Bosuk M, Montz F. Vaginal hysterectomy by uterine morcellation: an efficient, non-morbid procedure. Obstet Gynecol. 1995;86(1):60–4. doi:10.1016/0029-7844(95)00086-7.\nJenkins TR. Laparoscopic supracervical hysterectomy. Am J Obstet Gynecol. 2004;191(6):1875–84. doi:10.1016/j.ajog.2004.06.096.\nBerner E, Qvigstad E, Myrvold AK, Lieng M. Pelvic pain and patient satisfaction after laparoscopic supracervical hysterectomy: prospective trial. J Minim Invasive Gynecol. 2013. doi:10.1016/j.jmig.2013.10.011.\nAlkatout I, Mettler L, Beteta C, Hedderich J, Jonat W, Schollmeyer T, et al. Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial. J Minim Invasive Gynecol. 2013;20(4):473–81. doi:10.1016/j.jmig.2013.01.019.\nSemm K. Hysterectomy via laparotomy or pelviscopy. A new CASH method without colpotomy. Geburtshilfe Frauenheilkd. 1991;51(12):996–1003. doi:10.1055/s-2008-1026252.\nAcknowledgments\nThe authors wish to thank Dawn Rüther for editing the manuscript.\nCompliance with Ethics Guidelines\nᅟ\nConflict of Interest\nIbrahim Alkatout declares that he has no conflict of interest.\nHuman and Animal Rights and Informed Consent\nThis article does not contain any studies with human or animal subjects performed by any of the authors.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nAlkatout, I. Surgical Treatment of Fibroids. Curr Obstet Gynecol Rep 3, 207–215 (2014). https://doi.org/10.1007/s13669-014-0090-y\nPublished:\nIssue date:\nDOI: https://doi.org/10.1007/s13669-014-0090-y","source_license":"CC0","license_restricted":false}